Cannabis explained
Medical Cannabis and Neurological Conditions: What the Evidence Shows
Could medical cannabis help with MS, Parkinson’s, epilepsy or nerve pain? We explore what the research shows and where questions remain…
Cannabis explained
Could medical cannabis help with MS, Parkinson’s, epilepsy or nerve pain? We explore what the research shows and where questions remain…
Endometriosis
News Editor ·
News
Jodie Yettram ·
Events
Jodie Yettram ·
Journalism built on science, not speculation.
Upcoming Symposium
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
26 November 2026
London · Conway Hall
Lessons from medical cannabis markets across Europe will be explored at this week’s Cannabis Health Symposium in Frankfurt, with a focus on improving prescribing and patient care in Germany.
Endometriosis affects an estimated 190 million people worldwide, and gaps in care are leading to an increased interest in cannabis-based medicines. What do we know about how these might help, and does the science support it?
Copeia co-founder Garvin Hirt will join researchers in Frankfurt to discuss how politicians and doctors should make cannabis decisions when evidence is incomplete.
Science & Evidence — Spotlight
We read the studies so you don’t have to — separating robust findings from headlines, with the methods and caveats laid bare.
Explore the research
Plain-language guides to conditions, cannabinoids and what the evidence actually says.
Explore patient guidesRegulatory change, clinical evidence and the patient perspective for prescribers and pharmacists.
Enter the clinical hubWhy clinicians attend the symposiumDirectory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposium
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
26 November 2026
London · Conway Hall